Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905148-24-003139
Filing Date
2024-11-14
Accepted
2024-11-14 16:16:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13ga_no2_mygn.htm SC 13G/A 97873
  Complete submission text file 0000905148-24-003139.txt   99560
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Subject) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48577 | Film No.: 241462601
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 767 FIFTH AVENUE 44TH FLOOR NEW YORK NY 10153
Business Address 767 FIFTH AVENUE 44TH FLOOR NEW YORK NY 10153 2128124700
GLENVIEW CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001138995 (see all company filings)

EIN.: 134136746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A